Hyaluronate Increases Polynucleotides Effect on Human Cultured Fibroblasts


The HA is present in almost all vertebrates and plays a critical role in tissue development and cell proliferation, it has been demonstrated to promote wound healing and involved in angiogenesis and inflammation. Also polynucleotydes (PN) have proved to promote the “in vitro” growth and activity of human fibroblasts and osteoblasts, to increase reparation on UVB damaged dermal fibroblasts and seems to promote proliferation of human pre-adipocytes. Several in vivo studies have demonstrated the PN effect also in vivo, inducing an increase of angiogenesis and healing process. In this paper we have evaluated the effect of a mixture of Polynucleotides (PN) and entire Hyaluronic Acid (HA) on cultured human fibroblasts by analyzing cell growth. Different mixture have been tested and it has been demonstrated that the presence of HA even at low concentration (1 mg/ml) determine an increase of PN activity up to 20%. Furthermore, the addition of HA 1 mg/ml to PN 100 μg/ml induces a cell growth rate comparable to that exerted by PN concentration of 12 μg/ml.

Share and Cite:

S. Guizzardi, J. Uggeri, S. Belletti and G. Cattarini, "Hyaluronate Increases Polynucleotides Effect on Human Cultured Fibroblasts," Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 3 No. 1, 2013, pp. 124-128. doi: 10.4236/jcdsa.2013.31019.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] S. Thellung, T. Florio, A. Maragliano, G. Cattarini and G. Schettini, “Polydeoxyribonucleotides Enhance the Proliferation of Human Skin Fibroblasts: Involvement of A2 Purinergic Receptor Subtypes,” Life Sciences, Vol. 64, No. 18, 1999, pp. 1661-1674. doi:10.1016/S0024-3205(99)00104-6
[2] P. Sini, A. Denti, G. Cattarini, M. Daglio, M. E. Tira and C. Balduini, “Effect of Polydeoxyribonucleotides on Human Fibroblasts in Primary Culture,” Cell Biochemistry and Function, Vol. 17, No. 2, 1999, pp. 107-114. doi:10.1002/(SICI)1099-0844(199906)17:2<107::AID-CBF815>3.0.CO;2-#
[3] O. Muratore, G. Cattarini, S. Gianoglio, E. L. Tonoli, S. C. Sacca, D. Ghiglione, D. Venzano, C. Ciurlo, P. B. Lantieri and G. C. Schito, “A Human Placental Polydeoxyribonucleotide (PDRN) May Promote the Growth of Human Corneal Fibroblasts and Iris Pigment Epithelial Cells in Primary Culture,” New Microbiologica, Vol. 26, No. 1, 2003, pp. 13-26.
[4] S. Guizzardi, C. Galli, P. Govoni, R. Boratto, G. Cattarini, D. Martini, S. Belletti and R. Scandroglio, “Polydeoxyribonucleotide (PDRN) Promotes Human Osteoblast Proliferation: A New Proposal for Bone Tissue Repair,” Life Sciences, Vol. 73, No. 15, 2003, pp. 1973-1983. doi:10.1016/S0024-3205(03)00547-2
[5] S. Belletti, J. Uggeri, R. Gatti, P. Govoni and S. Guizzardi, “Polydeoxyribonucleotide Promotes Cyclo-Butane Pyrimidine Dimer Repair in UVB-Exposed Dermal Fibroblasts,” Photodermatology, Photoimmunology & Photomedicine, Vol. 23, No. 6, 2007, pp. 242-249. doi:10.1111/j.1600-0781.2007.00320.x
[6] E. Raposio, C. Guida, R. Coradeghini, C. Scanarotti, A. Parodi, I. Baldelli, R. Fiocca and P. L. Santi, “In Vitro Polydeoxyribonucleotide Effects on Human Pre-Adipocytes,” Cell Proliferation, Vol. 41, No. 5, 2008, pp. 739-754. doi:10.1111/j.1365-2184.2008.00547.x
[7] P. Rubegni, G. De Aloe, C. Mazzatenta, L. Cattarini and M. Fimiani, “Clinical Evaluation of the Trophic Effect of Polydeoxyribonucleotide (PDRN) in Patients Undergoing Skin Explants. A Pilot Study,” Current Medical Research & Opinion, Vol. 17, No. 2, 2001, pp. 128-131.
[8] M. Lazzarotto, E. M. Tomasello and A. Caporossi, “Clinical Evaluation of Corneal Epithelialization after Photorefractive Keratectomy in Patients Treated with Polydeoxyribonucleotide (PDRN) Eye Drops: A Randomized, Double-Blind, Placebo-Controlled Trial,” European Journal of Ophthalmology, Vol. 14, No. 4, 2004, pp. 284-289.
[9] L. Valdatta, A. Thione, C. Mortarino, M. Buoro and S. Tuinder, “Evaluation of the Efficacy of Polydeoxyribonucleotides in the Healing Process of Autologous Skin Graft Donor Sites: A Pilot Study,” Current Medical Research & Opinion, Vol. 20, No. 3, 2004, pp. 403-408. doi:10.1185 /030079904125003116
[10] S. Guizzardi, D. Martini, B. Bacchelli, L. Valdatta, A. Thione, S. Scamoni, J. Uggeri and A. Ruggeri, “Effects of Heat Deproteinate Bone and Polynucleotides on Bone Regeneration: An Experimental Study on Rat,” Micron, Vol. 38, No. 7, 2007, pp. 722-728. doi:10.1016/j.micron.2007.05.003
[11] M. Galeano, A. Bitto, D. Altavilla, L. Minutoli, F. Polito, M. Calo, P. Lo Cascio, F. Stagno D’Alcontres and F. Squadrito, “Polydeoxyribonucleotide Stimulates Angiogenesis and Wound Healing in the Genetically Diabetic Mouse,” Wound Repair and Regeneration, Vol. 16, No. 2, 2008, pp. 208-217. doi:10.1111/j.1524-475X.2008.00361.x
[12] D. Altavilla, A. Bitto, F. Polito, H. Marini, L. Minutoli, V. Di Stefano, N. Irrera, G. Cattarini and F. Squadrito, “Polydeoxyribonucleotide (PDRN): A Safe Approach to Induce Therapeutic Angiogenesis in Peripheral Artery Occlusive Disease and in Diabetic Foot Ulcers,” Cardiovascular & Hematological Agents in Medicinal Chemistry, Vol. 7, No. 4, 2009, pp. 313-321. doi:10.2174/187152509789541909
[13] K. A. Jacobson and Z. G. Gao, “Adenosine Receptors as Therapeutic Targets,” Nature Reviews Drug Discovery, Vol. 5, No. 3, 2006, pp. 247-264. doi:10.1038/nrd1983
[14] B. P. Toole, “Hyaluronan in Morphogenesis,” Journal of Internal Medicine, Vol. 242, No. 1, 1997, pp. 35-40. doi:10.1046/j.1365-2796.1997.00171.x
[15] P. H. Weigel, V. C. Hascall and M. Tammi, “Hyaluronan Synthases,” The Journal of Biological Chemistry, Vol. 272, No. 22, 1997, pp. 13997-14000. doi:10.1074/jbc.272.22.13997
[16] N. Itano, T. Sawai, F. Atsumi, O. Miyaishi, S. Taniguchi, R. Kannagi, M. Hamaguchi and K. Kimata, “Selective Expression and Functional Characteristics of Three Mammalian Hyaluronan Synthases in Oncogenic Malignant Transformation,” The Journal of Biological Chemistry, Vol. 279, No. 18, 2004, pp. 18679-18687. doi:10.1074/jbc.M313178200
[17] W. Knudson, C. Biswas and B. P. Toole, “Interactions between Human Tumor Cells and Fibroblasts Stimulate Hyaluronate Synthesis,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 81, No. 21, 1984, pp. 6767-6771. doi:10.1073/pnas.81.21.6767
[18] L. Udabage, G. R. Brownlee, S. K. Nilsson and T. J. Brown, “The Over-Expression of HAS2, Hyal-2 and CD44 Is Implicated in the Invasiveness of Breast Cancer,” Experimental Cell Research, Vol. 310, No. 1, 2005, pp. 205-217. doi:10.1016/j.yexcr.2005.07.026
[19] O. Oksala, T. Salo, R. Tammi, L. Hakkinen, M. Jalkanen, P. Inki and H. Larjava, “Expression of Proteoglycans and Hyaluronan during Wound Healing,” Journal of Histochemistry & Cytochemistry, Vol. 43, No. 2, 1995, pp. 125-135. doi:10.1177/43.2.7529785
[20] P. H. Weigel, G. M. Fuller and R. D. LeBoeuf, “A Model for the Role of Hyaluronic Acid and Fibrin in the Early Events during the Inflammatory Response and Wound Healing,” Journal of Theoretical Biology, Vol. 119, No. 2, 1986, pp. 219-234. doi:10.1016/S0022-5193(86)80076-5
[21] M. T. Longaker, E. S. Chiu, N. S. Adzick, M. Stern, M. R. Harrison and R. Stern, “Studies in Fetal Wound Healing. V. A Prolonged Presence of Hyaluronic Acid Characterizes Fetal Wound Fluid,” Annals of Surgery, Vol. 213, No. 4, 1991, pp. 292-296. doi:10.1097/00000658-199104000-00003
[22] M. T. Longaker, E. S. Chiu, M. R. Harrison, T. M. Crombleholme, J. C. Langer, B. W. Duncan, N. S. Adzick, E. D. Verrier and R. Stern, “Studies in Fetal Wound Healing. IV. Hyaluronic Acid-Stimulating Activity Distinguishes Fetal Wound Fluid from Adult Wound Fluid,” Annals of Surgery, Vol. 210, No. 5, 1989, pp. 667-672. doi:10.1097/00000658-198911000-00016
[23] R. Tammi, S. Pasonen-Seppanen, E. Kolehmainen and M. Tammi, “Hyaluronan Synthase Induction and Hyaluronan Accumulation in Mouse Epidermis Following Skin Injury,” Journal of Investigative Dermatology, Vol. 124, No. 5, 2005, pp. 898-905. doi:10.1111/j.0022-202X.2005.23697.x
[24] K. Fukuda, H. Dan, M. Takayama, F. Kumano, M. Saitoh and S. Tanaka, “Hyaluronic Acid Increases Proteoglycan Synthesis in Bovine Articular Cartilage in the Presence of Interleukin-1,” Journal of Pharmacology and Experimental Therapeutics, Vol. 277, No. 3, 1996, pp. 1672-1675.
[25] G. A. Homandberg, F. Hui, C. Wen, K. E. Kuettner and J. M. Williams, “Hyaluronic Acid Suppresses Fibronectin Fragment Mediated Cartilage Chondrolysis: I. In Vitro,” Osteoarthritis Cartilage, Vol. 5, No. 5, 1997, pp. 309-319. doi:10.1016/S1063-4584(97)80035-0
[26] K. Takahashi, R. S. Goomer, F. Harwood, T. Kubo, Y. Hirasawa and D. Amiel, “The Effects of Hyaluronan on Matrix Metalloproteinase-3 (MMP-3), Interleukin-1Beta (IL-1Beta), and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene Expression during the Development of Osteoarthritis,” Osteoarthritis Cartilage, Vol. 7, No. 2, 1999, pp. 182-190. doi:10.1053/joca.1998.0207
[27] T. Mosmann, “Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays,” Journal of Immunological Methods, Vol. 65, No. 1-2, 1983, pp. 55-63. doi:10.1016/0022-1759(83)90303-4

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.